American College of Cardiology 71st Scientific Sessions: Science Preview, April 4, 2022

April 25th 2025

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Your daily dose of the clinical news you may have missed.

August 30th 2023

Prediabetes Affects More than 97 Million Americans but 77 Million of Them Are Not Aware

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

Samuel Dagogo-Jack, MD, DSc;Grace Halsey

April 18th 2025

Primary Viewpoints Episode 4: Lp(a): The Next CVD Target?

The mildly elevated glycemia of prediabetes is a pathological condition with serious risks for those 77 million, says endocrinologist Samuel Dagogo-Jack, MD, DSc.

Patient Care Editorial Staff

October 29th 2020

Prostate Cancer Screening: Balancing Benefits and Harms in an Evolving Landscape

Patrick Moriarty, MD, from the University of Kansas Medical Center, discusses the role of Lp(a) as a risk factor for cardiovascular disease and the phase 3 trials of a potential treatment.

Research That Is Changing Endocrinology: Advances, Challenges, and The Future, with Irl B Hirsch, MD

ACP 2025. Ruth Etzioni, PhD, discussed evidence-based approaches to screening for patients at average risk, start and stop criteria, MRI for follow-up screening, and other topics.

Endocrinology in 2024: Advances, Challenges, and The Future, with Irl B Hirsch, MD

Oral Semaglutide Cuts MACE Risk by 14% in High-Risk Adults: Daily Dose

ACP 2025: Irl B Hirsch, MD, reviewed findings from 8 papers published in 2024 that he believes have made or will make a difference in the practice or understanding of the clinical area.

Related Content

April 25th 2025

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Your daily dose of the clinical news you may have missed.

August 30th 2023

Prediabetes Affects More than 97 Million Americans but 77 Million of Them Are Not Aware

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

Samuel Dagogo-Jack, MD, DSc;Grace Halsey

April 18th 2025

Primary Viewpoints Episode 4: Lp(a): The Next CVD Target?

The mildly elevated glycemia of prediabetes is a pathological condition with serious risks for those 77 million, says endocrinologist Samuel Dagogo-Jack, MD, DSc.

Patient Care Editorial Staff

October 29th 2020

Prostate Cancer Screening: Balancing Benefits and Harms in an Evolving Landscape

Patrick Moriarty, MD, from the University of Kansas Medical Center, discusses the role of Lp(a) as a risk factor for cardiovascular disease and the phase 3 trials of a potential treatment.

Research That Is Changing Endocrinology: Advances, Challenges, and The Future, with Irl B Hirsch, MD

ACP 2025. Ruth Etzioni, PhD, discussed evidence-based approaches to screening for patients at average risk, start and stop criteria, MRI for follow-up screening, and other topics.